 At baseline patients will be 1:1 randomized to be either part of the intervention Group 1 or control Group 2 group. Patients in Group 1 will be supplied with the MUSETM headband InteraXon Inc., Toronto, Canada that is a tool for mindfulness meditation with neurofeedback. Patients in Group 2 will not undergo any study-related treatment. 